To further our mission, we annually award research grants to institutions and medical professionals whose research focuses on cancers that present the greatest opportunities for a homerun cancer cure.
Note: When clicking the "Submit Grant Application" button below you will be redirected to SnapGrant.com to complete the application process.
The Cure Starts Now has funded $22,574,694 in pediatric brain cancer research in partnership with the DIPG / DMG Collaborative. This includes 139 grants at over 100 hospitals in 17 countries.
University of Sydney - $100,000
Targeting hypoxia and mitochondrial metabolism with repurposing drugs as an approach of radiosensitization for diffuse intrinsic pontine gliomas.
University of Michigan Hospitals - $157,856
Therapeutic reversal of pre-natal pontine ID1 signaling in DIPG
Dayton Children's Hospital - $69,600
Responses of distinct cell populations to PDGFRA inhibitors in diffuse intrinsic pontine glioma.
Institute of Cancer Research - $121,863
Targeting Top3A-Amplified DIPG cells by Sirtuin inhibition.
Bambino Gesu Children's Hospital - $49,803
Using imaging mass cytometry to identify next generation imaging biomarkers in PHGG and DIPG.
Telethon Kids Institute - $49,512
Development of a new and effective therapy against Diffuse Intrinsic Pontine Glioma.
Funding of PBTCF 2019: PBTC-058 - $25,000
PBTC-058: Phase 2 Study of Intraventricular Omburtamab-based Radioimmunotherapy for Pediatric Patients with Recurrent Medulloblastoma and Ependymoma
Sydney Children’s Hospital - $175,089
Polyamine Pathway Metabolism as a Novel Therapeutic Option for Diffuse Intrinsic Pontine Glioma
Cincinnati Children's Hospital - $540,742
Expansion of the International DIPG Registry.
Bambino Gesú Children's Hospital - $99,382
Investigating the Role of DIPG-Derived Exosomes in Tumor Growth and Invasion.
Ann and Robert H. Lurie Children's Hospital of Chicago - $35,000
Credentialing an Improved DIPG Mouse Model.
The Institute of Cancer Research - $100,000
Short-pulse Ultrasound Delivery of Panobinostat for the Treatment of Diffuse Intrinsic Gliomas in Children